The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Valproic Acid Toxicity: Overview and Management
Abstract
Acute valproic acid intoxication is an increasing problem, accounting for more than 5000 calls to the American Association of Poison Control Centers in 2000. The purpose of this paper is to review the pharmacology and toxicology of valproic acid toxicity. Unlike earlier antiepileptic agents, valproic acid appears to function neither through sodium channel inhibition nor through direct gamma-aminobutyric acid agonism, but through an indirect increase in regional brain gamma-aminobutyric acid levels. Manifestations of acute valproic acid toxicity are myriad, and reflect both exaggerated therapeutic effect and impaired intermediary metabolism. Central nervous system depression is the most common finding noted in overdose, and may progress to coma and respiratory depression. Cerebral edema has also been observed. Although hepatotoxicity is rare in the acute overdose setting, pancreatitis and hyperammonemia have been reported. Metabolic and hematologic derangements have also been described. Management of acute valproic acid ingestion requires supportive care and close attention to the airway. The use of controversial adjunctive therapies, including extracorporeal drug elimination and L-carnitine supplementation, will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valproic acid hepatic fatalities: A retrospective review
Dreifuss, F. E., Santilli, N., Langer, D. H., Sweeney, K. P., Moline, K. A., & Menander, K. B. (1987) · Neurology · doi:10.1212/wnl.37.3.379 · Cited by 483
Litovitz, T. L., Schmitz, B. F., & Holm, K. C. (1989) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(89)90252-0 · Cited by 410
Mechanisms of action of valproate: a commentatory
Johannessen, C. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00013-9 · Cited by 399
American Academy of Clinical Toxicology, E. A. O. P. C. A. C. T. (1999) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-100102451 · Cited by 397
Litovitz, T. L., Klein-Schwartz, W., White, S., Cobaugh, D. J., Youniss, J., Omslaer, J. C., Drab, A., & Benson, B. E. (2001) · The American Journal of Emergency Medicine · doi:10.1053/ajem.2001.25272 · Cited by 392
(1997) · Journal of Toxicology: Clinical Toxicology · doi:10.3109/15563659709162569 · Cited by 386
Litovitz, T. L., Felberg, L., White, S., & Klein-Schwartz, W. (1996) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(96)90160-6 · Cited by 309
McLean, M. J., & Macdonald, R. L. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24966-7 · Cited by 273
Kesterson, J. W., Granneman, R. G., & Machinist, J. M. (1984) · Hepatology · doi:10.1002/hep.1840040609 · Cited by 250
Cytochrome P-450—Catalyzed Formation of Δ4-VPA, a Toxic Metabolite of Valproic Acid
Rettie, A. E., Rettenmeier, A. W., Howald, W. N., & Baillie, T. A. (1987) · Science · doi:10.1126/science.3101178 · Cited by 250
Reye-like syndrome associated with valproic acid therapy
Gerber, N., Dickinson, R. G., Harland, R. C., Lynn, R. K., Houghton, D., Antonias, J. I., & Schimschock, J. C. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80110-9 · Cited by 224
Litovitz, T. L., Bailey, K. M., Schmitz, B. F., Holm, K. C., & Klein-Schwartz, W. (1991) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(91)90216-7 · Cited by 207
Pharmacokinetics and bioavailability of sodium valproate
Klotz, U., & Antonin, K. H. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1977216736 · Cited by 202
Acute ammonia toxicity is mediated by the NMDA type of glutamate receptors
Marcaida, G., Felipo, V., Hermenegildo, C., Miñana, M.-D., & Grisolia, S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80404-5 · Cited by 197
l‐Carnitine Supplementation in Childhood Epilepsy: Current Perspectives
De Vivo, D. C., Bohan, T. P., Coulter, D. L., Dreifuss, F. E., Greenwood, R. S., Nordli, D. R., Shields, W. D., Stafstrom, C. E., & Tein, I. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01315.x · Cited by 170
Acute Hepatic Failure Associated with the Use of Sodium Valproate: Report of Two Fatal Cases
Suchy, F. J., Balistreri, W. F., Buchino, J. J., Sondheimer, J. M., Bates, S. R., Kearns, G. L., Stull, J. D., & Bove, K. E. (1979) · New England Journal of Medicine · doi:10.1056/nejm197904263001706 · Cited by 163
Valproic Acid and Metabolites: Pharmacological and Toxicological Studies
Nau, H., & Löscher, W. (1984) · Epilepsia · doi:10.1111/j.1528-1157.1984.tb05632.x · Cited by 144
SECONDARY HYPERAMMONÆMIA: A POSSIBLE MECHANISM FOR VALPROATE ENCEPHALOPATHY
Coulter, D. L., & Allen, R. (1980) · The Lancet · doi:10.1016/s0140-6736(80)91773-0 · Cited by 143
Review Article: Carnitine, Valproate, and Toxicity
Coulter, D. L. (1991) · Journal of Child Neurology · doi:10.1177/088307389100600102 · Cited by 142
The Role of Carnitine Supplementation During Valproic Acid Therapy
Raskind, J. Y., & El-Chaar, G. M. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19242 · Cited by 141
Evidence for a biochemical lesion in depression.
Leonard, B. E. (2000) · PubMed · Cited by 139
Löscher, W., & Nau, H. (1985) · Neuropharmacology · doi:10.1016/0028-3908(85)90028-0 · Cited by 135
Comprehensive Review of the Psychiatric Uses of Valproate
Davis, L. L., Ryan, W. G., Adinoff, B. H., & Petty, F. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200002001-00001 · Cited by 135
Venlafaxine Versus Fluvoxamine in the Treatment of Delusional Depression
Zanardi, R., Franchini, L., Serretti, A., Pérez, J., & Smeraldi, E. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0107 · Cited by 134
Mitochondrial diseases represent a risk factor for valproate‐induced fulminant liver failure
Krähenbühl, S., Brandner, S., Kleinle, S., Liechti, S., & Straumann, D. (2000) · Liver International · doi:10.1034/j.1600-0676.2000.020004346.x · Cited by 115
Hertz, L., Yu, A. C., Kala, G., & Schousboe, A. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00012-7 · Cited by 112
In vitro effects of valproate and valproate metabolites on mitochondrial oxidations
Ponchaut, S., HOOF, F. V., & Veitch, K. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90324-c · Cited by 108
Concentration-Effect Relationships of Valproic Acid
Chadwick, D. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510020-00003 · Cited by 104
Cotariu, D., & Zaidman, J. L. (1988) · Clinical Chemistry · doi:10.1093/clinchem/34.5.890 · Cited by 88
Franceschetti, S., Hamon, B., & Heinemann, U. (1986) · Brain Research · doi:10.1016/0006-8993(86)90135-6 · Cited by 86
Bipolar disorder: diagnostic challenges and treatment considerations.
Evans, D. L. (2000) · PubMed · Cited by 84
Valproic Acid Overdose and l-Carnitine Therapy
Ishikura, H., Matsuo, N., Matsubara, M., Ishihara, T., Takeyama, N., & Tanaka, T. (1996) · Journal of Analytical Toxicology · doi:10.1093/jat/20.1.55 · Cited by 77
Life Threatening Intoxication with Sodium Valproate
Andersen, G. Ø., & Ritland, S. (1995) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659509018000 · Cited by 75
Glutamine as a pathogenic factor in hepatic encephalopathy
Albrecht, J., & Dolinska, M. B. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1121 · Cited by 73
Abnormal metabolism of valproic acid in fatal hepatic failure
Kochen, W., Schneider, A., & Ritz, A. (1983) · European Journal of Pediatrics · doi:10.1007/bf00445664 · Cited by 72
High-Flux Hemodialysis without Hemoperfusion Is Effective in Acute Valproic Acid Overdose
Kane‐Gill, S. L., Constantiner, M., Staubus, A. E., Meinecke, C. D., & Sedor, J. R. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19387 · Cited by 67
An ever-increasing pharmacopoeia for the management of patients with bipolar disorder.
Nemeroff, C. B. (2000) · PubMed · Cited by 64
Effect of L‐Carnitine Supplementation on Acute Valproate Intoxication
Murakami, K., Sugimoto, T., Woo, M., Nishida, N., & Muro, H. (1996) · Epilepsia · doi:10.1111/j.1528-1157.1996.tb00634.x · Cited by 61
Thurston, J. H., Carroll, J. E., Hauhart, R. E., & Schiro, J. A. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90367-4 · Cited by 60
(2001) · PubMed · Cited by 59
Valproate-induced hepatic failure in a case of cytochrome?c oxidase deficiency
Chabrol, B., Mancini, J., Chrétien, D., Rustin, P., Münnich, A., & Pinsard, N. (1994) · European Journal of Pediatrics · doi:10.1007/bf01959226 · Cited by 59
Carnitine Deficiency in Epilepsy: Risk Factors and Treatment
Coulter, D. L. (1995) · Journal of Child Neurology · doi:10.1177/0883073895010002s05 · Cited by 58
The High Incidence of Valproate Hepatotoxicity in Infants May Relate to Familial Metabolic Defects
APPLETON, R. E., Farrell, K., Applegarth, D. A., Dimmick, J. E., Wong, L., & Davidson, A. G. F. (1990) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100030353 · Cited by 53
Pathophysiology of Brain Edema in Fulminant Hepatic Failure, Revisited
Blei, A. T. (2001) · Metabolic Brain Disease · doi:10.1023/a:1011670713730 · Cited by 52
Acute valproate intoxication: biochemical investigations and hemodialysis treatment.
Mortensen, P. B., Hansen, H. E., Pedersen, B. K., Hartmann‐Andersen, F., & Husted, S. (1983) · PubMed · Cited by 51
Letter to the Editor: A Mechanism for Valproate-Induced Hyperammonemia
Coudé, F. X., Rabier, D., Cathelineau, L., Grimber, G., Parvy, P., & Kamoun, P. (1981) · Pediatric Research · doi:10.1203/00006450-198106000-00020 · Cited by 49
Hardy, J. R., Rees, E., Gwilliam, B., Ling, J., Broadley, K. E., & A’Hern, R. (2001) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00266-9 · Cited by 49
Cerebral edema following acute sodium valproate overdose
Khoo, S. H., & Leyland, M. J. (1992) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659209038632 · Cited by 48
Graudins, A., & Aaron, C. K. (1996) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563659609013799 · Cited by 47
Hyperammonemia and Coma without Hepatic Dysfunction Induced by Valproate Therapy
Barrueto, F. F., & Hack, J. B. (2001) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2001.tb01102.x · Cited by 43
Matsumoto, J., Ogawa, H., MAEYAMA, R., Okudaira, K., Shinka, T., Kuhara, T., & Matsumoto, I. (1997) · Epilepsia · doi:10.1111/j.1528-1157.1997.tb01263.x · Cited by 41
Valproic-Acid-Induced Pancreatitis: Case Report and Review of the Literature
Binek, J., Hany, A., & Heer, M. (1991) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199112000-00016 · Cited by 40
Reimherr, F. W., Strong, R. E., Marchant, B. K., Hedges, D. W., & Wender, P. H. (2001) · PubMed · Cited by 37
Kondo, T., Ishida, M., Kaneko, S., Hirano, T., Otani, K., Fukushima, Y., Muranaka, H., Koide, N., Yokoyama, M., Nakata, S., et al. (1992) · Epilepsia · doi:10.1111/j.1528-1157.1992.tb01708.x · Cited by 29
Alshareef, A., Buss, D. C., Shetty, H. G. M., Ali, N., & Routledge, P. (1997) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1997.tb00146.x · Cited by 25
Alonso, E., Girbés, J., García‐España, A., et al. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90219-1 · Cited by 24
Unusual electronmicroscopic changes in valproate-associated liver failure
Caparros-Lefebvre, D., Lecomte-Houcke, M., Pruvot, F., Declerck, N., Paris, J., & Petit, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90748-6 · Cited by 13
Cited by
European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances
Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., González-Salvado, V., Hinkelbein, J., Nolan, J. P., Paal, P., Perkins, G. D., Thies, K.-C., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.011 · Cited by 789
Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
Silva, M. F. B., Aires, C. C. P., Luis, P. B. M., Ruiter, J. P. N., IJlst, L., Duran, M., Wanders, R. J. A., & Tavares de Almeida, I. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0841-x · Cited by 382
Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance
Zhou, S., Chan, E., Duan, W., Huang, M., & Chen, Y.-Z. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-200028812 · Cited by 274
Carnitine in the treatment of valproic acid-induced toxicity
Lheureux, P. E. R., & Hantson, P. (2009) · Clinical Toxicology · doi:10.1080/15563650902752376 · Cited by 274
Lheureux (2005) · doi:10.1186/cc3742 · Cited by 176
Metadata
- Authors
- Sztajnkrycer, M. D.
- Venue
- Journal of Toxicology: Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 40
- Issue
- 6
- Pages
- 789-801
- ISSN
- 0731-3810 (ISSN-L)
- OpenAlex
- W2109115714
- Cited by
- 286
- References
- 57
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.